Join
Live feed
·
INSIDERFilingvia Quantisnow
Moleculin Biotech Inc. logo

Chief Financial Officer Foster Jonathan P. converted options into 834 shares and covered exercise/tax liability with 196 shares, increasing direct ownership by 12% to 6,011 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBRX (Moleculin Biotech Inc.) and more on Quantisnow.